MDWD
MediWound Ltd.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 5 ▼ MediWound reported a decline in Q4 and full-year 2025 revenue, drive…
- Apr 2 Contract: MediWound Reports BARDA Contract Award to Vericel for Nexo…
- May 29 to Jun 3 ▲ 3 days of insider buys: $136.0K by 3 insiders, avg $14.04
- Aug 26 to Sep 1 ▼ 3 days of insider sells: $82.1K by 2 insiders, avg $12.93
- Sep 1 ▲ 1 insider buy $6.6K at $12.62
- Sep 22 Contract: MediWound Awarded Additional $3.3 Million from U.S. Depart…
- Nov 5 ▼ MediWound filed a 6-K reporting the closing of a $17.25M underwritte…
- Nov 12 ▼ MediWound reported Q3 2026 revenue of $3.6M, down 33% YoY from $5.4M…
- Nov 12 ▲ Earnings: MDWD Q3 2026 Earnings: EPS $-0.65 (+9.8% vs est)
Signal stack
Where each data set points today.
- InsidersMIXED
3 insiders bought $142.7K at an average $13.97. 2 insiders sold $82.1K.
- InstitutionsMIXED
Q3 2026: 6 added (0 new), 7 trimmed or exited.
- Short sellersSTEADY
Short interest +2.3% to 1.79M shares. 14.7 days to cover, ≈12.4% of shares.
- TrendUPTREND
3% above its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| UBS Group AG | TRIM | $1.5M |
| Russell Investments Group, Ltd. | DOUBLED | $791.7K |
| Nuveen, LLC | ADD | $236.3K |
| FMR LLC | ADD | $133.7K |
| BARCLAYS PLC | DOUBLED | $56.0K |
| BNP PARIBAS FINANCIAL MARKETS | ADD | $33.6K |
| Arax Advisory Partners | TRIM | $15.8K |
| CITIGROUP INC | NEAR_EXIT | $14.2K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Aug 2026Price is below the lowest target. Median implies +121%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Aug 14, 2026 | Oppenheimer MAINTAIN | Outperform |
| May 28, 2026 | Oppenheimer MAINTAIN | Outperform |
| May 28, 2026 | HC Wainwright & Co. REITERATE | Buy |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Gonen Ofer Chief Executive Officer Nov 11, 2026 | EXERCISE | $110.1K |
Gonen Ofer Chief Executive Officer Nov 11, 2026 | EXERCISE | 8,168 sh |
Fox David Morton Director Nov 10, 2026 | EXERCISE | $88.0K |
Fox David Morton Director Nov 10, 2026 | EXERCISE | 6,534 sh |
SHAMIR NACHUM Director Nov 10, 2026 | EXERCISE | $220.1K |
SHAMIR NACHUM Director Nov 10, 2026 | EXERCISE | 16,336 sh |
Rubinstein Samuel Director Sep 1, 2026 | BUY | $6.6K |
Rubinstein Samuel Director Sep 1, 2026 | SELL | $6.7K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | -$0.60 | -$0.70–-$0.53 | +3.0% | $6.7M |
| Current FY | -$2.02 | -$2.21–-$1.85 | +9.5% | $18.4M |
| Next FY | -$2.24 | -$2.84–-$1.77 | +2.0% | $28.3M |
Short side
FINRA· Oct 30, 2026SecBot reports
10 filings · 3 press releases · 1 bullish · 6 bearish · 3 neutral- NEUTRAL SC 13G/ANov 13, 2026
Rosalind Advisors and related entities filed an amended Schedule 13G disclosing beneficial…
Monitor whether Rosalind Advisors files a Schedule 13D (activist intent) or continues to increase its position. The 9.1% stake is below the 10% threshold that would require more detailed disclosure…
- BEARISH 6-KNov 12, 2026
MediWound reported Q3 2026 revenue of $3.6M, down 33% YoY from $5.4M, and a net loss of $0.46 per…
The revenue miss and uncertain government funding outlook are the primary negatives, partially offset by the recent capital raise extending runway. Watch for updates on U.S. government funding…
- BEARISH PRESS-RELEASENov 12, 2026
MediWound reported Q3 2026 revenue of $3.6M, down 33% YoY from $5.4M, and a net loss of $0.46 per…
The revenue decline and cash burn underscore the need for U.S. government funding or additional capital. Monitor the EscharEx VALUE trial interim data in Q1 2027 and any resolution of the government…
- BEARISH 6-KNov 5, 2026
MediWound filed a 6-K reporting the closing of a $17.25M underwritten public offering of 1,380,000…
Monitor the Q3 2026 full results for further revenue and cash burn details, and watch for any updates on U.S. government development services revenue, which was cited as uncertain in the preliminary…
All MDWD filing & press-release reports (13)
- SC 13G/A reportNov 13, 2026
- 6-K reportNov 12, 2026
- PRESS-RELEASE reportNov 12, 2026
- 6-K reportNov 5, 2026
- 424B5 reportNov 5, 2026
- 424B5 reportNov 3, 2026
- PRESS-RELEASE reportSep 22, 2026
- CLUSTER reportJun 2, 2026
- PRESS-RELEASE reportMay 27, 2026
- PRESS-RELEASE reportMay 7, 2026
- 6-K reportMar 30, 2026
- PRESS-RELEASE reportMar 5, 2026
- PRESS-RELEASE reportMar 5, 2026